Showing results (211-220 of 259) with videos related to

Sort By:
Pageof 26
Frontiers in Oncology|July 15, 2021
Clinical, Radiometabolic and Immunologic Effects of Olaparib in Locally Advanced Triple Negative Breast Cancer: The OLTRE Window of Opportunity TrialFrancesco Schettini, Silvia Paola Corona, Fabiola Giudici, et al.
Oncotarget|October 4, 2017
Efficacy and safety of T-DM1 in the 'common-practice' of HER2+ advanced breast cancer setting: a multicenter studyAlessandra Fabi, Michelino De Laurentiis, Michele Caruso, et al.
ESMO Open|August 28, 2020
Oncological care organisation during COVID-19 outbreakConcetta Elisa Onesti, Hope S Rugo, Daniele Generali, et al.
Cell Death & Disease|February 17, 2025
Small molecule-mediated inhibition of the oxidoreductase ERO1A restrains aggressive breast cancer by impairing VEGF and PD-L1 in the tumor microenvironmentErsilia Varone, Michele Retini, Alessandro Cherubini, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|December 17, 2024
Circulating Tumor DNA Dynamics and Clinical Outcome in Metastatic Colorectal Cancer Patients Undergoing Front-Line ChemotherapyMichele Ghidini, Jens Claus Hahne, Chiara Senti, et al.
Cancer Treatment Reviews|August 29, 2024
Parp-inhibitors in the therapeutic landscape of breast cancer patients with BRCA1 and BRCA2 pathogenic germline variants: An Italian consensus paper and critical reviewAlberto Zambelli, Laura Cortesi, Mariangela Gaudio, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|July 17, 2026
Tumor infiltrating lymphocytes as a predictor of adjuvant avelumab efficacy in patients with high-risk triple negative breast cancerMaria Vittoria Dieci, Elisa Gasparini, Lorenzo Nicolè, et al.
International Journal of Infectious Diseases : IJID : Official Publication of the International Society for Infectious Diseases|January 1, 2021
Canakinumab as treatment for COVID-19-related pneumonia: A prospective case-control studyDaniele Generali, Giancarlo Bosio, Fabio Malberti, et al.
NPJ Breast Cancer|May 6, 2021
PONDx: real-life utilization and decision impact of the 21-gene assay on clinical practice in ItalyFrancesco Cognetti, Riccardo Masetti, Alessandra Fabi, et al.
Cancers|September 10, 2021
Anthracyclines Strike Back: Rediscovering Non-Pegylated Liposomal Doxorubicin in Current Therapeutic Scenarios of Breast CancerFrancesco Schettini, Mario Giuliano, Matteo Lambertini, et al.
Pageof 26